Selective, reversible direct factor Xa inhibitor used for stroke prevention and thromboembolic prophylaxis. Approved for atrial fibrillation, VTE prevention/treatment, and post-operative thromboprophylaxis.
Selectively and reversibly inhibits factor Xa in both intrinsic and extrinsic coagulation pathways, preventing thrombin formation and clot propagation. Superior efficacy-safety profile compared to warfarin in clinical trials.
Selectively and reversibly inhibits factor Xa in both intrinsic and extrinsic coagulation pathways, preventing thrombin formation and clot propagation. Superior efficacy-safety profile compared to warfarin in clinical trials.
© 2025[current_year] The Doctors Platform. All Right Reserved.
© 2025 The Doctors Platform. All Right Reserved.
